{
  "trial_id": "NCT01118091",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, ECOG performance status, absolute neutrophil count, white blood cell count, hemoglobin level, platelet count, HIV status, hepatitis B status, hepatitis C status, serum ALT/AST levels, creatinine clearance, total bilirubin level, prior systemic therapy, prior anti-CTLA4 antibody therapy, number of brain metastases, life expectancy, history of coronary revascularization, left ventricular ejection fraction, forced expiratory volume 1 (FEV1).",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "ECOG performance status",
        "absolute neutrophil count",
        "white blood cell count",
        "hemoglobin level",
        "platelet count",
        "HIV status",
        "hepatitis B status",
        "hepatitis C status",
        "serum ALT/AST levels",
        "creatinine clearance",
        "total bilirubin level",
        "prior systemic therapy",
        "prior anti-CTLA4 antibody therapy",
        "number of brain metastases",
        "life expectancy",
        "history of coronary revascularization",
        "left ventricular ejection fraction",
        "forced expiratory volume 1 (FEV1)."
      ]
    },
    "processed-gen-response": "Age, sex, race, ECOG performance status, absolute neutrophil count, white blood cell count, hemoglobin level, platelet count, HIV status, hepatitis B status, hepatitis C status, serum ALT/AST levels, creatinine clearance, total bilirubin level, prior systemic therapy, prior anti-CTLA4 antibody therapy, number of brain metastases, life expectancy, history of coronary revascularization, left ventricular ejection fraction, forced expiratory volume 1 (FEV1)."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count, White Blood Cell Count, Hemoglobin, Platelet Count, Serum ALT/AST, Creatinine Clearance, Total Bilirubin, Number of Brain Metastases, Prior Systemic Therapy, Prior Anti-CTLA4 Therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Absolute Neutrophil Count",
        "White Blood Cell Count",
        "Hemoglobin",
        "Platelet Count",
        "Serum ALT/AST",
        "Creatinine Clearance",
        "Total Bilirubin",
        "Number of Brain Metastases",
        "Prior Systemic Therapy",
        "Prior Anti-CTLA4 Therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Absolute Neutrophil Count, White Blood Cell Count, Hemoglobin, Platelet Count, Serum ALT/AST, Creatinine Clearance, Total Bilirubin, Number of Brain Metastases, Prior Systemic Therapy, Prior Anti-CTLA4 Therapy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, ECOG Performance Status, Number of Metastatic Sites, Prior Systemic Therapy, Prior Surgery, Prior Radiation Therapy, Baseline LDH, Baseline WBC, Baseline Hemoglobin, Baseline Platelet Count, Baseline Creatinine Clearance, Baseline Total Bilirubin, Baseline ALT/AST.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "ECOG Performance Status",
        "Number of Metastatic Sites",
        "Prior Systemic Therapy",
        "Prior Surgery",
        "Prior Radiation Therapy",
        "Baseline LDH",
        "Baseline WBC",
        "Baseline Hemoglobin",
        "Baseline Platelet Count",
        "Baseline Creatinine Clearance",
        "Baseline Total Bilirubin",
        "Baseline ALT/AST."
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, ECOG Performance Status, Number of Metastatic Sites, Prior Systemic Therapy, Prior Surgery, Prior Radiation Therapy, Baseline LDH, Baseline WBC, Baseline Hemoglobin, Baseline Platelet Count, Baseline Creatinine Clearance, Baseline Total Bilirubin, Baseline ALT/AST."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, weight, height, body mass index (BMI), performance status (ECOG), tumor size and location, number of metastases, prior systemic therapy, prior surgical therapy, absolute neutrophil count, white blood cell count, hemoglobin, platelet count, serum alanine aminotransferase (ALT)/aspartate aminotransferase (AST), calculated creatinine clearance, total bilirubin, life expectancy.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ],
        [
          "performance status (ECOG)",
          "performance status (ECOG)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "weight",
        "height",
        "body mass index (BMI)",
        "tumor size and location",
        "number of metastases",
        "prior systemic therapy",
        "prior surgical therapy",
        "absolute neutrophil count",
        "white blood cell count",
        "hemoglobin",
        "platelet count",
        "serum alanine aminotransferase (ALT)/aspartate aminotransferase (AST)",
        "calculated creatinine clearance",
        "total bilirubin",
        "life expectancy."
      ]
    },
    "processed-gen-response": "Age, sex, race, weight, height, body mass index (BMI), performance status (ECOG), tumor size and location, number of metastases, prior systemic therapy, prior surgical therapy, absolute neutrophil count, white blood cell count, hemoglobin, platelet count, serum alanine aminotransferase (ALT)/aspartate aminotransferase (AST), calculated creatinine clearance, total bilirubin, life expectancy."
  }
}